A Study to Look at the Safety of NNC0363-0845 in Healthy People and People With Type 1 Diabetes
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diabetes Mellitus - Type 1
- Healthy Volunteers
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Sequential AssignmentIntervention Model Description: Part 1 will be a placebo-controlled trial in healthy subjects; Part 2 will be an active-controlled trial in subjects with T1D. Part 3 of this trial, will be an open-label, two-period cross-over, randomised, single dose trial in subjects with T1D.Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Masking Description: Sponsor staff involved in the clinical trial is masked according to company standard procedures.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 55 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04569994
- Collaborators
- Not Provided
- Investigators
- Study Director: Clinical Transparency and Medical Writing Office (1452) Novo Nordisk A/S
Get Well Soon